Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-tocopherol is the most biologically significant form of Vitamin E and serves as a vital fat-soluble antioxidant within cellular and lipoprotein membranes. Its primary function is to protect polyunsaturated fatty acids (PUFAs) from oxidative damage by intercepting lipid peroxyl radicals, thereby terminating the self-propagating chain reaction of lipid peroxidation (NIH Office of Dietary Supplements, 2023). This protective mechanism is essential for maintaining the structural integrity and fluidity of biological membranes, which is critical for proper cell signaling and organelle function. Beyond its antioxidant capacity, alpha-tocopherol influences immune function and inhibits platelet aggregation by modulating protein kinase C activity (StatPearls, 2023). In clinical medicine, alpha-tocopherol is primarily used to treat or prevent Vitamin E deficiency, particularly in individuals with fat malabsorption syndromes or genetic disorders like Ataxia with Isolated Vitamin E Deficiency (AVED). It has also been extensively studied for its potential therapeutic benefits in slowing the progression of Alzheimer's disease and managing nonalcoholic steatohepatitis (NASH) (PubMed, PMID: 28805503). However, therapeutic use must be carefully monitored, as high doses can interfere with Vitamin K metabolism, leading to an increased risk of hemorrhage, especially in patients taking anticoagulant therapy (Mayo Clinic, 2023). The target name provided refers to a specific biochemical pathway (Reactome R-HSA-2046105) rather than a single protein receptor or enzyme.
Alpha-tocopherol acts as a chain-breaking antioxidant by donating a phenolic hydrogen atom to lipid peroxyl radicals (LOO•) generated during the initiation and propagation of lipid peroxidation. This reaction converts the highly reactive peroxyl radicals into relatively stable lipid hydroperoxides (LOOH) and produces a tocopheroxyl radical, which is less reactive and can be recycled back to alpha-tocopherol by other antioxidants like Vitamin C (StatPearls, 2023; NIH ODS, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-tocopherol (Vitamin E) (Vitamin E).